Spirulina and Vascular Smooth Muscle

The Phenotype Switch

Healthy VSMCs express contractile markers (α-SMA, calponin, SM-MHC) under myocardin transcriptional control. Injury, inflammation, or atherogenic stimuli induce KLF4 expression, shifting cells to synthetic phenotype with increased proliferation, ECM production, and migration. The switch drives intimal thickening in atherosclerosis, restenosis, and vascular remodeling.

Inflammation Drives Phenotype Switch

PDGF-BB, TNF-α, oxidized LDL, and TGF-β all promote VSMC phenotype switch. NF-κB activation drives KLF4 expression. Spirulina's broad anti-inflammatory effects reduce these pro-switch signals, with measurable preservation of α-SMA expression and contractile function in animal atherosclerosis models.

Vascular Calcification

Late-stage VSMC phenotype switch includes osteogenic transdifferentiation — expression of RUNX2 and matrix mineralization. This calcification stiffens arteries. Klotho deficiency (covered separately) promotes this transition. Spirulina's Klotho support and anti-inflammatory effects slow vascular calcification progression.

Conclusion

Spirulina preserves vascular smooth muscle contractile phenotype through reduced inflammatory drive of KLF4-mediated phenotype switch, with downstream effects on atherosclerosis progression, restenosis prevention, and reduced vascular calcification. The phenotype switch is reversible early but increasingly entrenched with chronic injury — emphasizing prevention.